Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

More documents

Recommendations

Info

86Annual Report on Lymphatic Filariasis 2003Chapter 3 Programme implementationFigure 3.112 Outcomes and planning 2000-2007No. of IUs40030020010002000200120022003Planned pop. coverage200420052006Figure 3.114 Geographical coverage% of at-risk population covered10075502501.8200013.2200120.02002No. IUs20072520151050Pop. reported to haveingested drugs49.22003Figure 3.116 IUs with reported coverage >65%million peopleApart from the supply of albendazole and routine supportfrom the department of health (of approximatelyUS$ 100 000), funds and resources to scale up the campaignfrom 2004 onwards are lacking. Firm pledgesand support are needed to sustain the momentum andachieve the objectives by 2010.Figure 3.113 LF at-risk populationPopulation in millions%807060504030201001009080706076.2Total pop.67.5 M73.2At-risk pop.23.5 MFigure 3.115 MDA reported coverage73.678.71008088.592.376.2 77.250200020012002200360%4020Figure 3.117 Updated mapping statusTotal: 1566 IUs500 IUs 693 IUs 373 IUs02000200120022003Uncertain Non-endemic Endemic
THAILAND87Endemicity statusEndemicNon-endemicUncertainAnnual Report on Lymphatic Filariasis 2003LF is one of the public health problems for Thailand’spopulation of approximately 62.3 million. Almost 0.2%of this population is considered at risk. The LF clinicalmanifestations evaluated recently in sentinel sites showan absence of cases of hydrocele and lymphoedema.The administrative division designated as an IU is thesubvillage. Mapping was completed in 1999 and, basedon microfilaraemia data, 336 IUs with an at-risk populationof 125 725 were considered endemic.The first round of MDA using albendazole and DEC beganin 2002 in all 336 endemic IUs. The second round beganin 2003, targeting 0.139 million people with a reportedcoverage of 89.0% (range: 51% to 100%)Between 2002 and 2003, 2563 drug distributors weretrained, and 211 people were given training in disabilityprevention and control.The LF elimination programme is implemented by theministry of health. WHO provided financial and technicalsupport. GSK donates albendazole to treat the wholepopulation. Future partnership initiatives envisaged arewith the Royal Thai Army, the Ministry of Defence andthe Department of Livestock Development, Ministry ofAgriculture and Cooperatives.Chapter 3 Programme implementationTable 3.26 Goal: to eliminate LF from Thailand by 2006Objectives• To interrupt LF transmissionStrategies• Community-wide MDA programmes to treat the entire at-risk population• To prevent disability associated with LF• Disability control in lymphoedema sufferers by using intensive butsimple, effective hygiene techniques
Page 1 and 2:
For further information about lymph
Page 3:
WHO/CDS/CPE/CEE/2005.52GlobalProgra
Page 7 and 8:
3Report of the Technical Advisory G
Page 9 and 10:
P R O G R A M M E H I G H L I G H T
Page 11:
I N T R O D U C T I O N7This Annual
Page 14 and 15:
10Annual Report on Lymphatic Filari
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41: 36Annual Report on Lymphatic Filari
Page 42 and 43: 38Figure 3.2 Outcomes and planning
Page 59 and 60: UNITED REPUBLIC OF TANZANIA55Endemi
Page 61 and 62: ZANZIBAR, UNITED REPUBLIC OF TANZAN
Page 63: 59AMERICAN PROGRAMME REVIEWGROUPAt
Page 86 and 87: 82Figure 3.100 Outcomes and plannin
Page 104 and 105: 100Annual Report on Lymphatic Filar
Page 118 and 119: 114Figure 3.196 Outcomes and planni
Page 127: C H A P T E R 6FURTHER DOCUMENTATIO
Page 135 and 136: ANNUAL REPORT FOR THE NATIONAL PROG
Page 137 and 138: 1332. PROGRAMME RESOURCES2.1 Please
Page 139 and 140: 1353.3 Interruption of transmission
Page 141 and 142:
1373.3.6a Report of MDA coverage by
Page 143 and 144:
1393.3.7 Surveys in sentinel sites
Page 145 and 146:
1413.3.10 Please attach a map of th
Page 147 and 148:
1434. SERIOUS ADVERSE EXPERIENCES (
Page 149 and 150:
A N N E X E SANNEX 3: LIST OF LF-EN
Page 151 and 152:
147RAPLOARPRGSAESEAROTAG-LFTDRUNDPU
Page 153 and 154:
149Drug administration and monitori
show all

Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?